Obalon

Obalon is a startup based in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Obalon develops a swallowable, gas-filled, FDA-approved intragastric balloon system designed to assist adults with a BMI of 30 to 40 kg/m2 in weight loss when combined with diet and exercise. The balloons must be removed within 6 months and are intended for patients without prior weight-loss surgeries.